GleamWall
中文EN

SVRA Savara Inc

Pharmaceutical Preparations · Nasdaq · SEC CIK 1160308 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-32.1%
TTM EPS YoY-13.2%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-151.0%
ROA-102.9%
ROIC (approx.)-114.7%
Asset turnover—

Leverage & solvency

Liabilities / assets30.8%
Debt / equity0.28x
Current ratio8.55x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.85x
Accruals ratio-15.1%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue——
R&D expense$81.40M$78.03M
SG&A expense$42.06M$25.04M
Operating income-$123.55M-$103.20M
Pretax income-$118.84M-$95.88M
Income tax$0$9,000
Net income-$118.84M-$95.88M
EBITDA-$123.46M-$103.07M
EPS (basic)-0.53-0.48
EPS (diluted)-0.53-0.48
Weighted avg. shares (diluted)222.39M198.19M
Balance sheet
Cash & equivalents$33.18M$15.13M
Short-term investments$202.52M$181.20M
Current assets$241.62M$202.13M
PP&E, net$100,000$165,000
Total assets$253.44M$212.88M
Current liabilities$20.40M$14.72M
Short-term debt$0$0
Long-term debt$29.91M$26.62M
Total debt$29.91M$26.62M
Total liabilities$50.30M$41.43M
Shareholders' equity$203.13M$171.45M
Net debt-$3.27M$11.49M
Shares outstanding204.57M172.42M
Cash flow statement
Operating cash flow-$101.04M-$89.09M
Capital expenditure$22,000$25,000
Free cash flow-$101.06M-$89.11M
Investing cash flow-$18.44M-$39.94M
Financing cash flow$137.81M$117.58M
Depreciation & amortization$87,000$130,000
Stock-based compensation$14.42M$9.86M

Free plan shows the latest 2 periods; Pro shows all 29 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.